Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-12-12

Clinical Trial Update: The Role of the EKG in Anticancer Drug Development

View source ↗

Summary

This update outlines the role of electrocardiography (EKG) in anticancer drug development and how cardiac monitoring can inform safety assessments in trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancer | Status: COMPLETED